Table 3.
Univariable Analysis Predicting OS in Stage IV Breast Cancer Patients
| Variable | N | HR (95% CI) | P value |
|---|---|---|---|
| Surgery (yes vs no) | 243 | 0.53 (0.36–0.86) | 0.002 |
| Age (<50 vs ≥50 yr) | 243 | 1.12(0.75–1.27) | 0.709 |
| Bone metastasis | 243 | 0.84 (0.63–1.63) | 0.746 |
| Visceral organ metastasis | 243 | 2.15 (1.22–3.86) | 0.000 |
| Number of metastases(continuous) | 243 | 1.24(0.69–1.54) | 0.054 |
| ER(+ vs.-) | 243 | 0.66 (0.59–0.94) | 0.001 |
| PR(+ vs.-) | 243 | 0.73 (0.58–0.82) | 0.029 |
| HER2(+ vs.-) | 243 | 1.46 (0.62–1.83) | 0.065 |
Abbreviations: HR, hazard ratio; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 2.